[1]. Ubiquitin-like 3 as a new protein-sorting factor for small extracellular vesicles.
Cell structure and function [巻]47 [号]1 [頁]1 -18 （2022年）
[DOI] [2]. 乳癌患者の妊娠・出産と生殖医療に関する診療ガイドライン改訂のポイント(乳癌関連)
日本がん・生殖医療学会誌 (一社)日本がん・生殖医療学会 [巻]5 [号]1 [頁]16 -22 （2022年）
[3]. A difficult-to-diagnose fibromatosis-like metaplastic carcinoma of the breast: a case report
[巻]7 [号]1 [頁]16 （2021年） [査読] 有
[4]. A difficult-to-diagnose fibromatosis-like metaplastic carcinoma of the breast: a case report
Surg Case Rep . [巻]7 [号]1 [頁]16 （2021年） [査読] 有
[5]. Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD)
Trials [巻]21 [号]1 [頁]391391 （2020年） [査読] 有
[6]. The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.
Breast cancer (Tokyo, Japan) （2020年） [査読] 有
[DOI] [7]. Preoperative concurrent endocrine therapy with chemotherapy in luminal B-like breast cancer.
Breast cancer (Tokyo, Japan) （2020年） [査読] 有
[DOI] [8]. Dose-dense adjuvant chemotherapy: a systematic review and meta-analysis of the Japanese Breast Cancer Society Clinical Practice Guideline, 2018 edition.
Breast cancer (Tokyo, Japan) （2020年） [査読] 有
[DOI] [9]. Efficacy of denosumab for restoring normal bone mineral density in women receiving adjuvant aromatase inhibitors for early breast cancer.
Medicine [巻]98 [号]32 [頁]e16770 （2019年） [査読] 有
[DOI] [10]. 術後3年半で肺転移をきたした乳腺腺様嚢胞癌の1例
乳癌の臨床 (株)篠原出版新社 [巻]34 [号]4 [頁]355 -360 （2019年） [査読] 有
[11]. Effect of denosumab on low bone mineral density in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: 24-month results.
Breast cancer (Tokyo, Japan) [巻]26 [号]1 [頁]106 -112 （2019年） [査読] 有
[DOI] [12]. 放射線治療が奏効した乳癌眼瞼眼窩転移の1例
乳癌の臨床 (株)篠原出版新社 [巻]30 [号]6 [頁]549 -555 （2015年）
[13]. Two cases of diabetic mastopathy: MR imaging and pathological correlation.
Breast cancer (Tokyo, Japan) [巻]22 [号]5 [頁]552 -6 （2015年）
[DOI] [14]. 食道neuroendocrine carcinoma乳腺転移が示唆された1例
乳癌の臨床 (株)篠原出版新社 [巻]29 [号]6 [頁]617 -622 （2014年）
[15]. DNA methylation alterations of AXIN2 in serrated adenomas and colon carcinomas with microsatellite instability.
BMC cancer [巻]14 [頁]466 （2014年）
[DOI] [16]. Increased polyamine intake inhibits age-associated alteration in global DNA methylation and 1,2-dimethylhydrazine-induced tumorigenesis.
PloS one [巻]8 [号]5 [頁]e64357 （2013年）
[DOI] [17]. Human breast cancer tissues contain abundant phosphatidylcholine(36∶1) with high stearoyl-CoA desaturase-1 expression.
PloS one [巻]8 [号]4 [頁]e61204 （2013年）
[DOI] [18]. The accumulation of DNA demethylation in Sat α in normal gastric tissues with Helicobacter pylori infection renders susceptibility to gastric cancer in some individuals.
Oncology reports [巻]27 [号]6 [頁]1717 -25 （2012年）
[DOI] [19]. Aberrant methylation of PSD disturbs Rac1-mediated immune responses governing neutrophil chemotaxis and apoptosis in ulcerative colitis-associated carcinogenesis.
International journal of oncology [巻]40 [号]4 [頁]942 -50 （2012年）
[DOI] [20]. Array-based identification of common DNA methylation alterations in ulcerative colitis.
International journal of oncology [巻]40 [号]4 [頁]983 -94 （2012年）
[DOI] [21]. Aberrant methylation of the Pleckstrin and Sec7 domain-containing gene is implicated in ulcerative colitis-associated carcinogenesis through its inhibitory effect on apoptosis.
International journal of oncology [巻]40 [号]3 [頁]686 -94 （2012年）
[DOI] [22]. Identification of a potent epigenetic biomarker for resistance to camptothecin and poor outcome to irinotecan-based chemotherapy in colon cancer.
International journal of oncology [巻]40 [号]1 [頁]217 -26 （2012年）
[DOI]